Research location

Salamanca

Castille and León, Spain

Published trials25

Site observations25

Linked trials published25

Page1 / 1

Research activity in Salamanca

Castille and León, Spain

CureCurrent currently publishes aggregate city-level research activity for this location: 25 trials and 25 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Salamanca

25 linked trials · page 1 of 1

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)NCT06966700 · 2025-06-30 · 1 site observation

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.NCT06724159 · 2024-12-13 · 1 site observation

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.NCT07717268 · 2024-05-16 · 1 site observation

REACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist DevicesNCT07611188 · 2026-05-01 · 1 site observation

NOT_YET_RECRUITING

A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)NCT06504394 · 2024-10-14 · 1 site observation

ACTIVE_NOT_RECRUITING

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationNCT06200207 · 2024-04-01 · 1 site observation

ACTIVE_NOT_RECRUITING

A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.NCT04742413 · 2020-12-29 · 1 site observation

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerNCT03937154 · 2020-02-26 · 1 site observation

ACTIVE_NOT_RECRUITING

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior TreatmentsNCT03056755 · 2017-08-29 · 1 site observation

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCNCT02941926 · 2016-11-30 · 1 site observation

Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical PracticeNCT02655159 · 2016-01-01 · 1 site observation

Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.NCT02422615 · 2015-06-09 · 1 site observation

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionNCT02373813 · 2015-02-20 · 1 site observation

Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line MonochemotherapyNCT02403869 · 2014-03-12 · 1 site observation

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenNCT01985334 · 2014-02-14 · 1 site observation

Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) PatientsNCT02064868 · 2014-01-31 · 1 site observation

Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line TreatmentNCT02061085 · 2013-07-01 · 1 site observation

A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714713 · 2013-06-01 · 1 site observation

Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast CancerNCT01698918 · 2013-03-07 · 1 site observation

Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714661 · 2012-10-01 · 1 site observation

Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable SchizophreniaNCT01213836 · 2010-11-01 · 1 site observation

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsNCT00789854 · 2008-11-01 · 1 site observation

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to RisperidoneNCT00600756 · 2008-01-01 · 1 site observation

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's DiseaseNCT00501111 · 2007-07-01 · 1 site observation

(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate CancerNCT00673205 · 1995-09-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.